content top

PDT for CSCR: What is the Appropriate Dose?

Purpose: Visudyne is FDA-approved for management of exudative AMD but is probably much more commonly used off-label. According to the manufaturer’s label “Visudyne is not approved for use in other indications, in combination with another product, with reduced fluency, or with any other alteration to administration.” Both for exudative AMD and central serous chorioretinopathy photodynamic therapy with Visudyne is often...

Read More

How Many Days after Onset Is It Too Late to Evacuate Submacular Hemorrhage Secondary to AMD?

http://www.evrs.eu/medias/2006/congress/How-Many-Days-after-Onset-Is-It-Too-Late-to-Evacuate-Submacular-Hemorrhage-Secondary-to-AMD.swf Keye L. Wong, MD (Sarasota, FL), Melvin C. Chen, MD (Sarasota, FL), John H. Niffenegger, MD (Sarasota, FL) PURPOSE: Animal experiments with submacular hemorrhage suggest that irreversible photoreceptor damage may occur within 48 hours. tPA-assisted pneumatic hemodisplacement is a technique which can result...

Read More
content top